Guwahati: The Primary Healthtech Private Limited developed device Mobilab, is coming to the consumer market (Business to Consumer) within 2- 3 years. 

Speaking about Mobilab, Sahil Jagnani, founder and chief executive officer, of Primary Healthtech, said, “The vision of Mobilab is to make diagnosis available to fellow citizens at an affordable cost, along with generating instant results to speed up the early screening, disease management, and treatment. 

“Mobilab is also expected to perform import substitution under the make-in-India initiative of the Government of India.”, Jagnani.

Business North East spoke to one of the cofounder Ankit Choudhury, who said that in this device first one need to connect the device, then they need to enter the entire patient details like their pathology report, doctor’s requirement, etc. After that, they provide the cartridge. 

This cartridge is filled with a specific reagent which reacts with the specific compounds in the blood. For example, if one wants to do with liver function test. The user needs to fill the cartridge with the blood sample. They also give them a mixer device for proper and uniform mixing. 

The device detects what is the concentration in the particular serum sample. It gives the result via the mobile application. This is shown in the dashboard. This is communicated through bluetooth and other media.

Currently, they are exploring different markets in India. It costs about five percent of the auto/semi-auto analysers used in the pathological labs as told to Business North East by the cofounder.

They are currently talking with the distributors and retailers. They are deciding as to what could be the suitable price.

This device can be purchased by small clinics or laboratories. This can also be used by that lab which is opened with less capital expenditure. This device is very easy to use. Anyone who has a smartphone can use this device. 

This device is very portable and can be taken from place to place. They are planning to make it available for home care. This device has multiple parameters. The application is such that very high technical knowledge is not required. 

“In the next two or three years they are planning to enter the consumer market. One should have the proper training to draw out the blood”, said Ankit.

Incubated at the research park and the centre for nanotechnology in IIT Guwahati campus, with extensive research and development translational, and regulatory support from SWASTHA center for the excellence of MeitY, ICMR-DHR center of Excellence and BIRAC-DBT.

Its team of 30 engineers and researchers aims to make diagnostics frugal, portable, affordable, and accessible.

The device is operated through an IoT-enabled android app and can perform about 150 tests with a single charge of the battery, which enables a digitally connected ecosystem for its use even for the remotest locations of the nation and serves the last-mile population.

Mobilab is validated at various levels in hospitals such as Guwahati Medical College and Hospital, Guwahati Neurological Research Centre, Nemcare, Army Hospital, AIIMS New Delhi, and has been deployed in various parts of Assam, Maharashtra, Uttar Pradesh, Madhya Pradesh, Gujrat, Delhi, and Arunachal Pradesh.

This project received both government and private funding. As many as 12 investors invested in northeast India’s first Mobile V1 that aims to make diagnostics affordable and accessible.

ALSO READ: IIT Guwahati gadget can check glycemic index in your fast food